Skip to content

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02465476
Acronym
Telemalrares
Enrollment
212
Registered
2015-06-08
Start date
2015-01-06
Completion date
2018-05-30
Last updated
2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Disease

Keywords

skin disease, telemedicine

Brief summary

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

Interventions

PROCEDUREtelemedicine

treatment pathway organized by telemedicine

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* New patients suffering from a rare skin disease whatever pathology or age, which needs a take-over by this centre * Or patients already take-over by the centre but lost to follow-up for more than one year * Patients (and/or parents) who give their consents * Patients (and/or parents) able to fill in questionnaires

Exclusion criteria

* Pregnant or breast-feeding women. * Patients subject to a judicial safeguard order * Patients who need an emergency take-over * Patients followed by a doctor who does not have a computerized system or refuse to send data via the secured messaging

Design outcomes

Primary

MeasureTime frameDescription
Number of hospital visits6 monthsInterest of a procedure of telemedicine on the organization of the treatment pathway of patients affected by rare skin diseases in terms of change of the number of visit in hospital.

Secondary

MeasureTime frameDescription
Improvement of the treatment pathway and its organization6 monthsTraceability in the information system by composite criteria : number of completed application forms, number of meeting per month, number of meeting a month, number of patients treated a month, time dedicated to the logistical coordination (collection by sheets of weekly time) and number of new patients per month.
Satisfaction of the patient6 monthsquestionnaire of satisfaction Short Form-36 Health Survey (SF36)
Change of the cost related to the patient care (direct and indirect).6 monthsComposite criteria with number of consultations and hospitalizations, number of visit in hospital and number of days of work and school absenteeism.
management of time by the medical personal.6 monthscollection by sheets of weekly time

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026